The oral microbiome of early stage Parkinson’s disease and its relationship with functional measures of motor and non-motor function
Open accessThe DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Abstract
Changes in the function and microbiome of the upper and lower gastrointestinal tract have been documented in Parkinson's disease (PD), although most studies have examined merely fecal microbiome profiles and patients with advanced disease states. In the present study we sought to identify sensitive and specific biomarkers of changes in the oral microbiome of early stage PD through shotgun metatranscriptomic profiling. We recruited 48 PD subjects and 36 age- and gender-matched healthy controls. Subjects completed detailed assessments of motor, cognitive, balance, autonomic and chemosensory (smell and taste) functions to determine their disease stage. We also obtained a saliva sample for profiling of microbial RNA and host mRNA using next generation sequencing. We found no differences in overall alpha and beta diversity between subject groups. However, changes in specific microbial taxa were observed, including primarily bacteria, but also yeast and phage. Nearly half of our findings were consistent with prior studies in the field obtained through profiling of fecal samples, with others representing highly novel candidates for detection of early stage PD. Testing of the diagnostic utility of the microbiome data revealed potentially robust performance with as few as 11 taxonomic features achieving a cross-validated area under the ROC curve of 0.90 and overall accuracy of 84.5%. Bioinformatic analysis of 167 different metabolic pathways supported shifts in a small set of distinct pathways involved in amino acid and energy metabolism among the organisms comprising the oral microbiome. In parallel with the microbial analysis, we also examined the evidence for changes in human salivary mRNAs in the same subjects. This revealed significant changes in a set of 9 host mRNAs, several of which mapped to various brain functions and showed correlations with some of the significantly changed microbial taxa. Unexpectedly, we also observed robust correlations between many of the microbiota and functional measures, including those reflecting cognition, balance, and disease duration. These results suggest that the oral microbiome may represent a highly-accessible and informative microenvironment that offers new insights in the pathophysiology of early stage PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Concerning PD, oral features associated with the disease such as dysphagia, salivary pH and drooling may influence the oral microbiota by altering the β-diversity index and favoring the growth of opportunistic oral microbes and Lactobacillus species, which may exacerbate the clinical symptoms and correlate with worse Hamilton Anxiety Scale and Hamilton Depression Rating Scale scores [70,496,497].”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [497]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“There was a strong correlation between the alterations in oral-specific microbial taxa and functional indexes in patients with Parkinson's disease.48”
From The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options (2021) · cites this paper as [48]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Because of dysbiosis, the aminoacidic and energetic metabolisms associated with oral bacteria vary [497].”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [497]
The cited source says what the claim attributes to it.
In the citing paper
“For example, the combination of 11 taxonomic features associated with the oral microbiota has allowed PD diagnosis reaching up to 84.5% accuracy, but better performances are expected to come [497].”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [497]
In the citing paper
“Of note, these alterations can modulate the expression of salivary host mRNAs involved in multiple brain activities, thus supporting the relationship between oral microbiota and cognitive disorders [497].”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [497]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MDS clinical diagnostic criteria for Parkinson’s disease
Postuma, R. B., Berg, D., Stern, M., Poewe, W., Olanow, C. W., Oertel, W., Obeso, J., Marek, K., Litvan, I., Lang, A. E., et al. (2015) · Movement Disorders · doi:10.1002/mds.26424 · Cited by 7,653
Kalia, L. V., & Lang, A. E. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61393-3 · Cited by 6,184
Role of Streptococcus mutans in human dental decay
Loesche, W. J. (1986) · Microbiological Reviews · doi:10.1128/mr.50.4.353-380.1986 · Cited by 6,171
Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
Cryan, J. F., & Dinan, T. G. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3346 · Cited by 4,572
Bravo, J. A., Forsythe, P., Chew, M. V., Escaravage, E., Savignac, H. M., Dinan, T. G., Bienenstock, J., & Cryan, J. F. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102999108 · Cited by 3,888
Goetz, C. G., Poewe, W., Rascol, O., Sampaio, C., Stebbins, G. T., Counsell, C., Giladi, N., Holloway, R. G., Moore, C. G., Wenning, G. K., et al. (2004) · Movement Disorders · doi:10.1002/mds.20213 · Cited by 2,347
Serotonin, tryptophan metabolism and the brain-gut-microbiome axis
O’Mahony, S. M., Clarke, G., Borre, Y. E., Dinan, T. G., & Cryan, J. F. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.07.027 · Cited by 2,012
Gut microbiota are related to Parkinson's disease and clinical phenotype
Scheperjans, F., Aho, V., Pereira, P. A. B., Koskinen, K., Paulin, L., Pekkonen, E., Haapaniemi, E., Kaakkola, S., Eerola‐Rautio, J., Pohja, M., et al. (2015) · Movement Disorders · doi:10.1002/mds.26069 · Cited by 1,968
Dhariwal, A., Chong, J., Habib, S., King, I. L., Agellon, L. B., & Xia, J. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx295 · Cited by 1,885
α-Synuclein Promotes SNARE-Complex Assembly in Vivo and in Vitro
Burré, J., Sharma, M., Tsetsenis, T., Buchman, V., Etherton, M. R., & Südhof, T. C. (2010) · Science · doi:10.1126/science.1195227 · Cited by 1,812
Cited by
Microbiota in health and diseases
Hou, K., Wu, Z.-X., Chen, X.-Y., Wang, J.-Q., Zhang, D., Xiao, C., Zhu, D., Koya, J. B., Wei, L., Li, J., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00974-4 · Cited by 3,171
“In a cross-sectional case control design study on PD, around 16 bacterial families were found to be altered in early-stage PD patients.(284) Among them, variation in families like Bifidobacteriaceae, Saccharomycetaceae and Lactobacillaceae were studied extensively for their role in progression of PD.”
BackgroundThe role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options
Wang, Q., Luo, Y., Ray Chaudhuri, K., Reynolds, R., Tan, E.-K., & Pettersson, S. (2021) · Brain · doi:10.1093/brain/awab156 · Cited by 281
Progress in Oral Microbiome Related to Oral and Systemic Diseases: An Update
Lee, Y.-H., Chung, S. W., Auh, Q.-S., Hong, S.-J., Lee, Y.-A., Jung, J., Lee, G.-J., Park, H. J., Shin, S.-I., & Hong, J.-Y. (2021) · Diagnostics · doi:10.3390/diagnostics11071283 · Cited by 168
“Neurodegenerative disorders, such as Alzheimer’s disease [145] and Parkinson’s disease [146] have also been reported to be associated with the oral microbiome.”
BackgroundDiet in Parkinson’s Disease: Critical Role for the Microbiome
Jackson, A., Forsyth, C. B., Shaikh, M., Voigt, R. M., Engen, P. A., Ramirez, V., & Keshavarzian, A. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.01245 · Cited by 145
“The majority of PD human studies employed bacterial 16S ribosomal RNA (rDNA amplicons) sequencing to different variable regions to identify bacteria in feces (majority of studies), colonic sigmoid mucosa (98), nasal wash (105) or nasal swab and oral (106, 107) samples.”
BackgroundMethodEmerging role of the host microbiome in neuropsychiatric disorders: overview and future directions
Hashimoto, K. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02287-6 · Cited by 157
“Notably, the oral microbiota in early-stage PD patients shows signi fi cant differences compared to healthy controls, with speci fi c oral bacteria exhibiting associations with motor and non-motor functional measures [112].”
BackgroundThe gut microbiome in Parkinson's disease: A culprit or a bystander?
(2020) · Progress in Brain Research · doi:10.1016/bs.pbr.2020.01.004 · Cited by 103
Oral Dysbiosis and Inflammation in Parkinson’s Disease
Fleury, V., Zekeridou, A., Lazarević, V., Gaïa, N., Giannopoulou, C., Genton, L., Cancela, J., Girard, M., Goldstein, R., Bally, J. F., et al. (2021) · Journal of Parkinson s Disease · doi:10.3233/jpd-202459 · Cited by 107
“65], Veillonella [37], Lactobacillaceae [37, 38] and”
BackgroundInfluentialVaresi, A., Campagnoli, L. I. M., Fahmideh, F., Pierella, E., Romeo, M., Ricevuti, G., Nicoletta, M., Chirumbolo, S., & Pascale, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012289 · Cited by 88
Oral and Gut Dysbiosis Leads to Functional Alterations in Parkinson’s Disease
Jo, S., Kang, W., Hwang, Y. S., Lee, S. H., Park, K. W., Kim, M. S., Lee, H., Yoon, H. J., Park, Y. K., Chalita, M., et al. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-022-00351-6 · Cited by 85
Microbiome changes: an indicator of Parkinson’s disease?
Haikal, C., Chen, Q., & Li, J. (2019) · Translational Neurodegeneration · doi:10.1186/s40035-019-0175-7 · Cited by 89
Ghosh, T. S., Arnoux, J., & O’Toole, P. W. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1822729 · Cited by 71
Oral Health Disorders in Parkinson’s Disease: More than Meets the Eye
Auffret, M., Meuric, V., Boyer, É., Bonnaure‐Mallet, M., & Vérin, M. (2021) · Journal of Parkinson s Disease · doi:10.3233/jpd-212605 · Cited by 78
“Conversely, the impact of PD on oral microbiota [204], chronic inflammation, neurodegeneration and the gut brain axis need to be thoroughly explored ([81, 148], BUCCO-PARK study, NCT03965390 4 ).”
InfluentialKaur, G., Behl, T., BUNGAU, S. G., Kumar, A., Uddin, M. S., Mehta, V., Zengin, G., Mathew, B., Shah, M. A., & Arora, S. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200606233050 · Cited by 63
“also observed a greater abundance of Lactobacillaceae in PD patient's saliva relative to controls [84].”
BackgroundOral microbiome variations related to ageing: possible implications beyond oral health
Kazarina, A., Kuzmicka, J., Bortkevica, S., Zayakin, P., Ķimsis, J., Igumnova, V., Sadovska, D., Freimane, L., Kivrāne, A., Namiņa, A., et al. (2023) · Archives of Microbiology · doi:10.1007/s00203-023-03464-5 · Cited by 64
“’s study revealed increase in the abundance of oral Lactobacillus in patients suffering from Parkinson’s disease (Mihaila et al. 2019; Wu et al. 2021b).”
BackgroundKim, H. S., Son, J. L., Lee, D., Tsai, J., Wang, D., Chocrón, E. S., Jeong, S., Kittrell, P., Murchison, C., Kennedy, R., et al. (2022) · BMC Neurology · doi:10.1186/s12883-022-02586-5 · Cited by 58
“For example, in PD patients, oral microbiome changes were highly predictive of their impairments in locomotion, balance, and cognition [22].”
BackgroundOral Factors That Impact the Oral Microbiota in Parkinson’s Disease
Rozas, N. S., Tribble, G. D., & Jeter, C. B. (2021) · Microorganisms · doi:10.3390/microorganisms9081616 · Cited by 58
“This is in agreement with previous reports [9,10].”
ResultThe oropharyngeal microbiome is altered in individuals with schizophrenia and mania
Yolken, R. H., Prandovszky, E., Severance, E. G., Hatfield, G. S., & Dickerson, F. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.03.010 · Cited by 48
Changes in the stool and oropharyngeal microbiome in obsessive-compulsive disorder
Domènech, L., Willis, J. R., Alemany-Navarro, M., Morell, M., Real, E., Escaramís, G., Bertolín, S., Chinchilla, D. S., Balcells, S., Segalàs, C., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-05480-9 · Cited by 52
Danilenko, V., Devyatkin, A., Marsova, M., Shibilova, M., Ilyasov, R. A., & Shmyrev, V. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s333887 · Cited by 57
Association of perturbation of oral bacterial with incident of Alzheimer's disease: A pilot study
Moghadam, M. T., Amirmozafari, N., Mojtahedi, A., Bakhshayesh, B., Shariati, A., & Jazi, F. M. (2022) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.24483 · Cited by 54
The evolutionary history of the human oral microbiota and its implications for modern health
Weyrich, L. S. (2020) · Periodontology 2000 · doi:10.1111/prd.12353 · Cited by 53
Gut dysbiosis and age-related neurological diseases in females
Korf, J. M., Ganesh, B. P., & McCullough, L. D. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105695 · Cited by 49
Mosaddad, S. A., Mahootchi, P., Safari, S., Rahimi, H., & Aghili, S. S. (2023) · Journal of Basic Microbiology · doi:10.1002/jobm.202300141 · Cited by 43
“[81], the pathophysiology of early stage PD can be well explained using the oral microbiome as an informative and highly accessible microenvironment [81].”
BackgroundDeidda, G., & Biazzo, M. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.753915 · Cited by 40
The faecal metabolome and mycobiome in Parkinson's disease
Pablo‐Fernández, E. D., Gebeyehu, G. G., Flain, L., Slater, R., Frau, A., Ijaz, U. Z., Warner, T. T., & Probert, C. S. (2022) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2022.01.005 · Cited by 37
The Role of the Western Diet and Oral Microbiota in Parkinson’s Disease
Zapała, B., Stefura, T., Milewicz, T., Wątor, J., Piwowar, M. W., Wójcik-Pędziwiatr, M., Doręgowska, M., Dudek, A., Jania, Z., & Rudzińska, M. (2022) · Nutrients · doi:10.3390/nu14020355 · Cited by 39
Oral and intestinal dysbiosis in Parkinson's disease
Berthouzoz, E., Lazarević, V., Zekeridou, A., Jiménez, M. C., Debove, I., Aybek, S., Schrenzel, J., Burkhard, P. R., & Fleury, V. (2023) · Revue Neurologique · doi:10.1016/j.neurol.2022.12.010 · Cited by 39
Gastrointestinal Dysfunction in Parkinson’s Disease
Safarpour, D., Sharzehi, K., & Pfeiffer, R. F. (2022) · Drugs · doi:10.1007/s40265-021-01664-1 · Cited by 40
Xu, S., Li, W., & Di, Q. (2022) · European Neurology · doi:10.1159/000527537 · Cited by 36
Oral and gut microbial profiling in periodontitis and Parkinson’s disease
Yay, E., Yılmaz, M., Toygar, H. U., Balcı, N., Rivas, C. A., Kılıç, B. B., Zirh, A. T., Paster, B. J., & Kantarcı, A. (2024) · Journal of Oral Microbiology · doi:10.1080/20002297.2024.2331264 · Cited by 32
Predictive analysis methods for human microbiome data with application to Parkinson’s disease
Dong, M., Li, L., Chen, M., KUSALIK, A. J., & Xu, W. (2020) · PLoS ONE · doi:10.1371/journal.pone.0237779 · Cited by 32
Assessing saliva microbiome collection and processing methods
Armstrong, A. J. S., Parmar, V., & Blaser, M. J. (2021) · npj Biofilms and Microbiomes · doi:10.1038/s41522-021-00254-z · Cited by 31
Nutrition and Lifestyle Interventions for Managing Parkinson’s Disease: A Narrative Review
Lister, T. (2020) · Journal of Movement Disorders · doi:10.14802/jmd.20006 · Cited by 34
Clasen, F., Yıldırım, S., Arıkan, M., García-Guevara, F., Hanoğlu, L., Yılmaz, N. H., Şen, A., Celik, H. K., Alagöz, A. N., Demir, T. K., et al. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2506843 · Cited by 38
“24– 26 These biofilms, often associated with gingivitis and periodontitis, 27 enable bacteria to enter the blood-stream, potentially causing bacteremia and systemic inflammation.”
Arıkan, M., Demir, T. K., Yıldız, Z., Nalbantoğlu, Ö. U., Korkmaz, N. D., Yılmaz, N. H., Şen, A., Özcan, M., Muth, T., Hanoğlu, L., et al. (2023) · npj Biofilms and Microbiomes · doi:10.1038/s41522-023-00452-x · Cited by 29
Microbial Symphony: Navigating the Intricacies of the Human Oral Microbiome and Its Impact on Health
Bhandary, R., Venugopalan, G., Ramesh, A., Tartaglia, G., Singhal, I., & Khijmatgar, S. (2024) · Microorganisms · doi:10.3390/microorganisms12030571 · Cited by 33
“Furthermore, research also suggests that the oral microbiota, specifically some species within it, may have associations with systemic disorders, including Parkinson’s disease [23], type II diabetes mellitus [24], GI malignancies [25], inflammatory bowel disease (IBD) [26], and obesity [27].”
BackgroundQamar, M. A., Rota, S., Batzu, L., Subramanian, I., Falup‐Pecurariu, C., Titova, N., Metta, V., Murășan, I., Odin, P., Padmakumar, C. P., et al. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1174698 · Cited by 20
“To identify Porphyromonas gingivalis, the possibility of detecting gingipains in the bloodstream, particularly gingipain R1, and the analysis of the oral microbiota through a saliva sample, should be explored further (116, 117, 119).”
BackgroundPursuing Multiple Biomarkers for Early Idiopathic Parkinson’s Disease Diagnosis
Gopar‐Cuevas, Y., Duarte-Jurado, A. P., Diaz-Perez, R., Cárdenas, O. S., Loera‐Arias, M. D. J., Montes‐de‐Oca‐Luna, R., Rodríguez‐Rocha, H., & García‐García, A. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02500-z · Cited by 20
Association between oral dysbiosis and Parkinson’s disease: a systematic review
Murcia, L., Sánchez-García, A., Pecci‐Lloret, M. P., & Rodríguez‐Lozano, F. J. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1564362 · Cited by 18
Modulation of oral microbiota: A new frontier in exercise supplementation
Bescós, R., Brookes, Z. L. S., Belfield, L., Fernández‐Sanjurjo, M., & Casas‐Agustench, P. (2020) · PharmaNutrition · doi:10.1016/j.phanu.2020.100230 · Cited by 16
“From this viewpoint, recent studies have shown that the oral microbiome of patients with neurodegenerative diseases such as Parkinson’s and Alzheimer’s diseases differ to the microbiome of healthy individuals (116, 117).”
Regulation of Pain Perception by Microbiota in Parkinson Disease
Manjarres, Z., Calvo, M., & Pacheco, R. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000674 · Cited by 15
Comparative analysis of oral microbiome from Zang and Han populations living at different altitudes
Yu, H., Tang, C., Du, Q., Zhou, X., Peng, X., & Cheng, L. (2020) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2020.104986 · Cited by 16
Self-citationOral Microbiota: Discovering and Facing the New Associations with Systemic Diseases
Patini, R. (2020) · Pathogens · doi:10.3390/pathogens9040313 · Cited by 13
The Effect of Bacterial Composition Shifts in the Oral Microbiota on Alzheimer's Disease
Moghadam, M. T., Mojtahedi, A., Bakhshayesh, B., Babakhani, S., Ajorloo, P., Shariati, A., Mirzaei, M., Heidarzadeh, S., & Jazi, F. M. (2022) · Current Molecular Medicine · doi:10.2174/1566524023666220819140748 · Cited by 12
Clostridioides difficile and neurological disorders: new perspectives
Biazzo, M., Allegra, M., & Deidda, G. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.946601 · Cited by 11
“Also, gut microbiome dysfunctions are common (Hamano et al., 1993; Clairembault et al., 2015; Hasegawa et al., 2015; Keshavarzian et al., 2015; Klingelhoefer and Reichmann, 2015; Mulak and Bonaz, 2015; Unger et al., 2016; Bedarf et al., 2017; Hill-Burns et al., 2017; Parashar and Udayabanu, 2017; Scheperjans et al., 2…”
BackgroundOral Dysbiosis and Neuroinflammation: Implications for Alzheimer’s, Parkinson’s and Mood Disorders
Zavala-Medina, L. C., Salas‐Leiva, J. S., Villegas‐Mercado, C. E., Arreguín-Cano, J. A., Soto‐Barreras, U., Santana-Delgado, S. A., Larrinúa-Pacheco, A. D., Vega, M. F. G., & Bermúdez, M. (2026) · Microorganisms · doi:10.3390/microorganisms14010143 · Cited by 11
“Recent research has established a connection between oral microbiota and PD, revealing distinct oral bacterial compositions in individuals with PD compared to healthy subjects [70,139,140].”
Oral and gut microbiome profiles in people with early idiopathic Parkinson’s disease
Stagaman, K., Kmiecik, M. J., Wetzel, M., Aslibekyan, S. W., Sönmez, T. F., Fontanillas, P., Auton, A., Babalola, E., Bell, R. K., Bielenberg, J., et al. (2024) · Communications Medicine · doi:10.1038/s43856-024-00630-8 · Cited by 19
“…in which many (but not all) studies report greater stool microbiome richness in PD cases versus controls 5,30,32,34 , whereas, for the saliva microbiome, alpha-diversity is often reported as not signi fi cantly different 32,36,37 , or studies con fl ict as to whether it is greater or lower 15,35 .”
InfluentialZhang, W., Qi, T., Yao, L., Wang, W., Yu, F., Yan, Y., Salama, E., Su, S., & Bai, M. (2022) · Microbial Ecology · doi:10.1007/s00248-021-01951-0 · Cited by 9
Microbiota Orchestra in Parkinson’s Disease: The Nasal and Oral Maestros
Rei, N., Grunho, M., Mendes, J. J., & Fonseca, J. (2024) · Biomedicines · doi:10.3390/biomedicines12112417 · Cited by 12
“Several studies have illuminated the dysregulation of the oral microbiota in PD [16,21,35].”
Umamahesan, C., Pilcicka, A., Yick, J., Baker, K., Smith, M. H., Taylor, D. M., Ma, Y., Mullish, B. H., Marchesi, J. R., Gilbert, S., et al. (2025) · Biochemical Journal · doi:10.1042/bcj20240621 · Cited by 10
“In saliva [45], there was increased abundance of three species from the phylum Ascomycota.”
Bian, M., Chen, L., & Lei, L. (2022) · Journal of Zhejiang University (Medical Sciences) · doi:10.3724/zdxbyxb-2021-0111 · Cited by 11
Disease mechanisms as subtypes: Microbiome
Bonvegna, S., & Cilia, R. (2023) · Handbook of clinical neurology · doi:10.1016/b978-0-323-85555-6.00006-0 · Cited by 8
Mechanisms of oral microflora in Parkinson's disease
Wang, B., Zhang, C. M., Shi, C., Zhai, T., Zhu, J., Wei, D., Shen, J., Liu, Z., Jia, K., & Zhao, L. (2024) · Behavioural Brain Research · doi:10.1016/j.bbr.2024.115200 · Cited by 12
A Clinically Validated Human Saliva Metatranscriptomic Test for Global Systems Biology Studies
Toma, R., Cai, Y., Ogundijo, O., Hu, L., Gline, S., Demusaj, D., Duval, N., Torres, P. J., Camacho, F. R., Banavar, G. S., et al. (2023) · BioTechniques · doi:10.2144/btn-2022-0104 · Cited by 7
Personalized Dentistry: Approaching a New Way for Diagnosis and Treatment of Oral Diseases
Patini, R. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10020035 · Cited by 9
Gastrointestinal dysfunction in Parkinson's disease
Timpka, J., & Odin, P. (2021) · International review of movement disorders · doi:10.1016/bs.irmvd.2021.07.004 · Cited by 7
Zheng, Q., Zhang, Y., Li, J., Pei, S., Liu, J., Lu, F. F., Zhang, L., Liu, X., Luo, B., Ruan, Y., et al. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1502812 · Cited by 7
Vo, T. T. T., Tsai, M.-H., Cheng, C.-Y., Wang, Y.-L., Lee, W.-J., & Lee, I. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117362 · Cited by 7
Moghadam, M. T., Ramírez‐Coronel, A. A., Darijani, S., Akbarizadeh, M. R., Naderifar, M., Soltaninejad, S., Shahbazi, S., Dousari, A. S., Mojtahedi, A., & Akhavan‐Sigari, R. (2023) · Current Alzheimer Research · doi:10.2174/1567205020666230718160914 · Cited by 7
Effects of antimicrobial exposure on the risk of Parkinson's disease
Pal, G. D., Bennett, L., Roy, J. A., Nyandege, A. N., Mouradian, M. M., Gerhard, T., & Horton, D. B. (2024) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2024.107081 · Cited by 7
Neto, D. P. A., & Sant’Ana, A. S. (2023) · Fungal Biology Reviews · doi:10.1016/j.fbr.2023.100327 · Cited by 6
Changes in Oral Microbial Diversity in a Piglet Model of Traumatic Brain Injury
Jeon, J. H., Lourenco, J. M., Fagan, M. M., Welch, C. B., Sneed, S. E., Dubrof, S., Duberstein, K. J. J., Callaway, T. R., West, F. D., & Park, H. J. (2022) · Brain Sciences · doi:10.3390/brainsci12081111 · Cited by 5
Gustatory dysfunction is related to Parkinson's disease: A systematic review and meta‐analysis
Kwak, I., Kim, K. S., & Min, H. J. (2023) · International Forum of Allergy & Rhinology · doi:10.1002/alr.23158 · Cited by 6
“20,21,23,27,32,34,36 Questionnaires were the second most common method (five studies), 24,25,30,31,35 followed by taste solution tests (three studies) 10,22,28 and PTU/PTC perception tests (two studies).”
BackgroundMethodThe Immune System Response to Porphyromonas gingivalis in Neurological Diseases
Franciotti, R., Pignatelli, P., D’Antonio, D. L., Mancinelli, R., Fulle, S., Rosa, M. A. D., Puca, V., Piattelli, A., Thomas, A. M., ONOFRJ, M. C., et al. (2023) · Microorganisms · doi:10.3390/microorganisms11102555 · Cited by 5
Nurkolis, F., Utami, T. W., Alatas, A. I., Wicaksono, D., Kurniawan, R., Ratmandhika, S. R., Sukarno, K. T., Pahu, Y. G. P., Kim, B., Tallei, T. E., et al. (2024) · Frontiers in Aging · doi:10.3389/fragi.2024.1462569 · Cited by 6
Soy and the gut microbiome: a bi-directional relationship shaping nutrition and health
Nolan, L., & O’Toole, P. W. (2026) · European Journal of Nutrition · doi:10.1007/s00394-026-03900-4 · Cited by 5
Role of Nutraceuticals and Physical Activity in Parkinson's Disease Risk and Lifestyle Management
Wal, P., Vig, H., Wal, A., Rathore, S., Pandey, S. S., Jain, N. K., & Srivastava, A. (2023) · Current Aging Science · doi:10.2174/1874609816666230515121717 · Cited by 5
İpek, E. D., & Başaloğlu, H. (2025) · Folia Morphologica · doi:10.5603/fm.104808 · Cited by 3
Yarahmadi, A., Emrahoglu, S., Afkhami, H., Mehdipour, A., & Aghaali, M. (2025) · Antonie van Leeuwenhoek · doi:10.1007/s10482-025-02190-w · Cited by 5
“Unlike gut microbiota, data on oral microbiota in PD are scarce (Pereira et al. 2017; Mihaila et al. 2019).”
Oral–Gut Microbiota Crosstalk and Epigenetic Targets in Metabolic and Neuropsychiatric Diseases
Mostafavi, S., Nohesara, S., Pirani, A., Abdolmaleky, H. M., & Thiagalingam, S. (2025) · Nutrients · doi:10.3390/nu17213367 · Cited by 5
Evaluation of an Adapted Semi-Automated DNA Extraction for Human Salivary Shotgun Metagenomics
Meslier, V., Menozzi, E., David, A., Morabito, C., Pozo, S. L. D., Famechon, A., North, J. M., Quinquis, B., Koletsi, S., Macnaughtan, J., et al. (2023) · Biomolecules · doi:10.3390/biom13101505 · Cited by 3
“…highlighted the detection and potential influence of the oral microbiome in numerous human diseases such as liver cirrhosis, type 2 diabetes, rheumatoid arthritis, COVID-19 infection, colorectal and pancreatic cancers [1–10], and neurodegenerative diseases such as Parkinson’s disease (PD) [11–14].”
Ge, Z., Chen, J., Chen, X., Zhang, R., Zhang, Y., & Luo, W. F. (2025) · BMC Oral Health · doi:10.1186/s12903-025-06448-7 · Cited by 5
“…suggested that oral microflora may be altered in PD patients from the early stages, with higher amounts of cariogenic and periodontal pathogens such as Streptococcus mutans , Lactobacillus , and Firmicutes compared to controls, potentially increasing the risk for caries and periodontitis [19, 20].”
Bacterial Profiles of Brain in Downer Cattle with Unknown Etiology
Park, Y.-J., Kang, G.-U., Jeong, M., Singh, V., Kim, J., Lee, K., Choi, E., Kim, H.-J., Lee, S., Lee, S., et al. (2022) · Microorganisms · doi:10.3390/microorganisms11010098 · Cited by 3
“Especially, movement disorder through complication of encephalitis was detected to mice which inject with Rhodococcus genus [43].”
BackgroundDie Rolle des Darmmikrobioms beim idiopathischen Parkinson-Syndrom
Unger, M. M., Becker, A., Keller, A., Schäfer, K., Schwiertz, A., & Oertel, W. H. (2020) · Der Nervenarzt · doi:10.1007/s00115-020-01011-x · Cited by 3
Oral microbiota and central nervous system diseases: A review
Zhang, X., Zhong, M., Li, Y., Wang, H., Xi, G., Wang, F., Cheng, C., & Shi, Y. (2025) · Neuroprotection/Neuroprotection (Chichester, England. Print) · doi:10.1002/nep3.75 · Cited by 4
“61 Both the saliva and sub-gingival dental plaque microbiota in patients with PD show a higher abundance of Streptococcus mutans ( S. mutans ), Kingella oralis , Actinomyces AFQCs , Veillo-nella AFUJs , Scardovia , Lactobacillaceae , Negativi-cutes , and Firmicutes , which may be associated with…”
Medical and Psychosocial Considerations in Older Adults
Preston, J., & Wilkinson, I. (2022) · BDJ clinician's guides · doi:10.1007/978-3-031-10224-0_4 · Cited by 3
Blood microbiome signatures in the REM sleep behavior disorder–Lewy body disease continuum
Kim, R., Oh, S., Woo, K. A., Shin, C. M., Park, K. U., & Lee, J. (2025) · Journal of Neural Transmission · doi:10.1007/s00702-025-02953-9 · Cited by 2
“…et al. 2023; Nishiwaki et al. 2020), with some trends overlapping but different from those seen in PD. Additionally, distinct microbiota signatures in oral (Jo et al. 2022; Pereira et al. 2017; Li et al. 2022; Mihaila et al. 2019) and deep nasal (Pal et al. 2021) cavities have been reported in PD.”
Zhang, M., Du, M., Zhang, W., Huang, R., Li, W., Li, T., Bai, J., Zhang, N., Chen, J., Zhou, J., et al. (2026) · iMetaMed · doi:10.1002/imm3.70033 · Cited by 2
Jin, H., Meng, L., Yuluğ, B., Altay, Ö., Li, X., Çankaya, Ş., Hanoğlu, L., Ji, B., Coşkun, E., İdil, E., et al. (2026) · Neurobiology of Disease · doi:10.1016/j.nbd.2026.107424 · Cited by 1
Efectos de la disbiosis en la cavidad oral y su relación con la enfermedad de Parkinson
Tapia, E. J. C., & Jurado, S. A. L. (2022) · Revista Científica Especialidades Odontológicas UG · doi:10.53591/eoug.v5i1.1400 · Cited by 1
Rajeev, A., & Chattopadhyay, I. (2024) · Springer eBooks · doi:10.1007/978-981-99-8803-7_13 · Cited by 1
Evaluation of an adapted semi-automated DNA extraction for human salivary shotgun metagenomicsPreprint
Meslier, V., Menozzi, E., David, A., Morabito, C., Pozo, S. L. D., Famechon, A., North, J. M., Quinquis, B., Koletsi, S., Macnaughtan, J., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-2762553/v2 · Cited by 1
Noninvasive Acquisition of Oral Mucosal Epithelial miRNA and Bacteria DNA/RNA from a Single Site
Adami, G. R. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1518-8_12
Oral Health in Parkinson’s Disease: How Long are we Going to Neglect it?
Orsini, M. (2021) · Archives in Neurology & Neuroscience · doi:10.33552/ann.2021.10.000749
“A study conducted by Mihaila (2019) [6] and collaborators, aimed to identify changes in the function and microbiome of the upper and lower gastrointestinal tract that have been documented in Parkinson’s disease (PD).”
MethodEvaluation of an adapted semi-automated DNA extraction for human salivary shotgun metagenomicsPreprint
Almeida, M., Meslier, V., Menozzi, E., David, A., Morabito, C., Pozo, S. L. D., Famechon, A., North, J. M., Quinquis, B., Koletsi, S., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-2762553/v1
Daalen, J. M. J., Gerritsen, A., Gerritse, G., Gouman, J., Meijerink, H., Rietdijk, L. E., & Darweesh, S. K. L. (2024) · Brain Sciences · doi:10.3390/brainsci14040358
Надання стоматологічних послуг у форматі 3П медицини
Yusko, L., & Брехлічук, П. П. (2024) · Intermedical journal · doi:10.32782/2786-7684/2024-1-31
Hisamatsu, D., Masuoka, H., Takeshige‐Amano, H., Hatano, T., Ogawa, T., Yamashiro, K., Kurokawa, R., Mabuchi, Y., Naraoka, Y., Asada, T., et al. (2026) · npj Biofilms and Microbiomes · doi:10.1038/s41522-026-01138-w
The oral phageome in human health, disease, and clinical implications
Wu, M., Xie, Y., Le, S., & Li, Y. (2026) · Journal of Applied Microbiology · doi:10.1093/jambio/lxag158
Alanazi, A. (2026) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.70307
“An altered mix of oral bacteria has also been observed in Parkinson's disease [136] and Alzheimer's disease [137].”
Furuya, H., Longnecker, D., Almazan, E., Hinojosa, O., Rochester, T., & Carnaby, G. (2026) · Journal of Oral Rehabilitation · doi:10.1111/joor.70326
Oral Microbiota Associated With Parkinson'S Disease: A Systematic Review
Abreu, M. D. S., de Morais, R. P. L., Pereira, T. F., Sales, P. H. D. H., Leão, J. C., & Carvalho, A. D. A. T. (2026) · Special Care in Dentistry · doi:10.1111/scd.70272
“Other genera, such as Veillonella , Megasphaera and Scardovia , were also considered, although less expressively, with an association of 27.3% [ 9, 10, 12, 14, 16, 19 ].”
Influential
Metadata
- Authors
- Mihaila, D., Donegan, J., Barns, S., LaRocca, D., Du, Q., Zheng, D., Vidal, M., Neville, C., Uhlig, R., & Middleton, F. A.
- Affiliations
- SUNY Upstate Medical University (US)
- Quadrant Biosciences (United States) (US)
- Corresponding author
- Middleton, Frank A.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2019-06-27
- Volume
- 14
- Issue
- 6
- Pages
- e0218252
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC6597068
- OpenAlex
- W2953419696
- Cited by
- 94
- References
- 76
- Citations by year
- 2026: 9 · 2025: 10 · 2024: 11 · 2023: 17 · 2022: 20 · 2021: 13 · 2020: 12 · 2019: 2
- FWCI
- 13.49
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Quadrant Biosciences
- Topics
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- Parkinson's disease, oral microbiota, early-stage Parkinson's disease, saliva, microbial RNA, biomarkers, diagnostic biomarkers, metatranscriptomics, microbial metabolic pathways, amino acid metabolism, energy metabolism, motor function, non-motor functions, cognition, balance, autonomic function, chemosensory function, disease duration
- MeSH terms
- Aged, Bacteria, Cognition, Female, Humans, Male, Motor Activity, Mouth, Parkinson Disease, Phylogeny, Reaction Time, RNA, Messenger, ROC Curve, Saliva, Biodiversity, Gene Regulatory Networks, Metabolic Networks and Pathways, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.